CVRx receives FDA approval for expanded labeling of
U.S. annual market opportunity increases based on real world adoption and strength of long-term BeAT-HF data...
Source: globenewswire.com
Clinical Summary News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clinical Summary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clinical Summary Today - Breaking & Trending Today
CVRx, Inc. Receives FDA Approval for Expanded Labing of Barostim
CVRx, Inc. announced that the U.S. Food and Drug Administration has approved revised Instructions For Use for Barostim incorporating key long-term clinical data from the BeAT-HF randomized clinical...
Source: marketscreener.com
U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS (mavacamten) Label
16.06.2023 - Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) to add positive data from the Phase 3 VALOR-HCM study to the U.S. Prescribing Information for ...
Source: wallstreet-online.de
Clinical Overview and Clinical Summary Training Course: Creating Effective Marketing Authorisation Applications - Regulatory Guidelines and Requirements of Module 2 (February 8-9, 2023)
/PRNewswire/ -- The "Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Training Course" conference has been added...
Source: prnewswire.com
April | 2011 | HIT Consultant
10 posts published by hitconsultant during April 2011
Source: hitconsultant.net